Solural Pharma has a total of 42 patents globally, out of which 24 have been granted. Of these 42 patents, more than 76% patents are active. Japan is where Solural Pharma has filed the maximum number of patents. Parallelly, Europe (EPO) seems to be the main focused R&D centre and
Xbiome has a total of 11 patents globally, out of which no patents have been granted. Of these 11 patents, all the patents are active. The USA is where Xbiome has filed the maximum number of patents, followed by China and Europe (EPO). Parallelly, China seems to be the main
Sumitomo Pharma has a total of 103 patents globally, out of which 29 have been granted. Of these 103 patents, more than 68% patents are active. The United States of America is where Sumitomo Pharma has filed the maximum number of patents, followed by Canada and Mexico. Parallelly, United States
Zhejiang Medicine has a total of 397 patents globally, out of which 237 have been granted. Of these 397 patents, more than 73% patents are active. China is where Zhejiang Medicine has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to
Cadrenal Therapeutics has a total of 7 patents globally, out of which 5 have been granted. Of these 7 patents, all patents are inactive. The United States of America is where Cadrenal Therapeutics has filed all their patents. Parallelly, United States of America seems to be the main focused R&D
Asymchem Laboratories has a total of 869 patents globally, out of which 448 have been granted. Of these 869 patents, more than 70% patents are active. China is where Asymchem Laboratories has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to
Abon Biopharma has a total of 348 patents globally, out of which 257 have been granted. Of these 348 patents, more than 39% patents are active. China is where Abon Biopharma has filed the maximum number of patents, followed by United States of America and Hong Kong (S.A.R.). Parallelly, China
Centaurus Biopharma has a total of 418 patents globally, out of which 238 have been granted. Of these 418 patents, more than 64% patents are active. China is where Centaurus Biopharma has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to
89Bio has a total of 77 patents globally, out of which 42 have been granted. Of these 77 patents, more than 87% patents are active. United States of America is where 89Bio has filed the maximum number of patents, followed by Canada and Hong Kong (S.A.R.). Parallelly, United States of
Invirsa has a total of 45 patents globally, out of which 23 have been granted. Of these 45 patents, more than 93% patents are active. United States of America is where Invirsa has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.